| Primary |
| Drug Use For Unknown Indication |
37.3% |
| Pulmonary Hypertension |
13.3% |
| Mean Arterial Pressure |
9.6% |
| Hypertension |
4.8% |
| Ventricular Dysfunction |
4.8% |
| Ventricular Failure |
4.8% |
| Cardiac Failure Congestive |
3.6% |
| Heart Transplant |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Thrombosis |
3.6% |
| Anticoagulant Therapy |
2.4% |
| Cardiac Disorder |
1.2% |
| Cardiac Failure Acute |
1.2% |
| Cardiac Output |
1.2% |
| Infection |
1.2% |
| Poor Peripheral Circulation |
1.2% |
| Spleen Disorder |
1.2% |
| Wrong Drug Administered |
1.2% |
|
| Ventricular Extrasystoles |
13.6% |
| Atrial Fibrillation |
9.1% |
| Death |
9.1% |
| Device Leakage |
9.1% |
| Intraventricular Haemorrhage Neonatal |
9.1% |
| Allergic Myocarditis |
4.5% |
| Cerebral Haemorrhage Neonatal |
4.5% |
| Device Failure |
4.5% |
| Hypertension |
4.5% |
| Hypotension |
4.5% |
| Overdose |
4.5% |
| Platelet Count Decreased |
4.5% |
| Septic Shock |
4.5% |
| Thrombocytopenia |
4.5% |
| Tricuspid Valve Incompetence |
4.5% |
| Wrong Drug Administered |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
30.2% |
| Pulmonary Hypertension |
11.8% |
| Mean Arterial Pressure |
9.4% |
| Drug Use For Unknown Indication |
6.7% |
| Cardiac Failure |
5.9% |
| Drug Therapy |
3.9% |
| Cardiac Failure Chronic |
3.5% |
| Infection |
3.5% |
| Cardiac Failure Acute |
3.1% |
| Nutritional Support |
3.1% |
| Cardiomyopathy |
2.4% |
| Pain |
2.4% |
| Vasoconstriction |
2.4% |
| Asthma |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Anticoagulant Therapy |
1.6% |
| Intraoperative Care |
1.6% |
| Pulmonary Embolism |
1.6% |
| Sedation |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
|
| Allergic Myocarditis |
13.9% |
| Tricuspid Valve Incompetence |
13.9% |
| Type Iv Hypersensitivity Reaction |
8.3% |
| Death |
5.6% |
| Intraventricular Haemorrhage Neonatal |
5.6% |
| Overdose |
5.6% |
| Renal Failure Chronic |
5.6% |
| Thrombosis In Device |
5.6% |
| Treatment Failure |
5.6% |
| Blood Chloride Decreased |
2.8% |
| Cardiac Fibrillation |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Drug Interaction |
2.8% |
| Heart Transplant |
2.8% |
| Hyperbilirubinaemia |
2.8% |
| Leukaemoid Reaction |
2.8% |
| Myocarditis |
2.8% |
| Renal Failure |
2.8% |
| Restrictive Cardiomyopathy |
2.8% |
| Tachycardia |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
60.2% |
| Drug Use For Unknown Indication |
17.9% |
| Coronary Artery Bypass |
5.1% |
| Mitral Valve Replacement |
1.9% |
| Aortic Valve Replacement |
1.6% |
| Cardiac Operation |
1.4% |
| Catheterisation Cardiac |
1.3% |
| Prophylaxis |
1.3% |
| Mitral Valve Repair |
1.1% |
| Acute Myeloid Leukaemia |
1.0% |
| Sedation |
0.9% |
| Hypertension |
0.8% |
| Tricuspid Valve Repair |
0.8% |
| Intra-aortic Balloon Placement |
0.8% |
| Ventricular Assist Device Insertion |
0.8% |
| Cardiac Failure |
0.7% |
| Pain |
0.7% |
| Heart Transplant |
0.6% |
| Anaesthesia |
0.6% |
| Cardiac Failure Congestive |
0.5% |
|
| Injury |
13.9% |
| Unevaluable Event |
10.1% |
| Fear |
8.9% |
| Pain |
8.9% |
| Anxiety |
8.0% |
| Anhedonia |
7.7% |
| Renal Failure |
6.4% |
| Emotional Distress |
4.8% |
| Stress |
3.9% |
| Renal Impairment |
3.6% |
| Renal Failure Acute |
3.0% |
| Ventricular Tachycardia |
3.0% |
| Depression |
2.8% |
| Renal Injury |
2.8% |
| Thrombocytopenia |
2.3% |
| Sepsis |
2.1% |
| Thrombosis |
2.1% |
| Multi-organ Failure |
2.0% |
| Death |
1.8% |
| Platelet Count Decreased |
1.8% |
|
| Interacting |
| Maintenance Of Anaesthesia |
25.0% |
| Pulmonary Embolism |
25.0% |
| Induction Of Anaesthesia |
16.7% |
| Pulmonary Hypertension |
16.7% |
| Muscle Relaxant Therapy |
8.3% |
| Nephroprotective Therapy |
8.3% |
|
| Tumour Haemorrhage |
100.0% |
|
